Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma

Reactivation of hepatitis B virus (HBV) is a well-known complication in patients with hematological malignancies during or after cytotoxic chemotherapy. If the initiation of antiviral therapy is delayed in patients with HBV reactivation, these patients can develop severe hepatitis and may die of ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukune, Yutaka, Sasaki, Makoto, Komatsu, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895787/
https://www.ncbi.nlm.nih.gov/pubmed/31752356
http://dx.doi.org/10.3390/cancers11111819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895787/
https://www.ncbi.nlm.nih.gov/pubmed/31752356
http://dx.doi.org/10.3390/cancers11111819

Ejemplares similares